Lipotropic injections may enhance fat loss when used alongside a healthy diet and exercise, though results vary
FDA procedurally removed it from Category 2 in April 2026 after nominators withdrew their submissions and referred it to the Pharmacy Compounding Advisory Committee, which is scheduled to review it on July 23-24, 2026 for possible inclusion on the approved 503A bulks list
Research-only status: Since DSIP is not FDA-approved, all current dosing practices remain experimental
Why it was included in the FDA ban While animal studies suggest that DIHEXA may tout these brain benefits (17), the FDA says it has not identified any human exposure data. Meaning: The safety and efficacy of DIHEXA for humans is still up in the air
99%+ Purity Lab Verified Lyophilized For Stability Research Grade Not for Human Use 1 In stock COA 99% Batch SEQ-BPC157-965 Tissue Research Description Body Protection Compound investigated in in vitro tissue repair studies and gastrointestinal research models
The advantages of this treatment include: Long-term weight loss One weekly injection Reduced appetite Increased Metabolism Improved overall health GLP-1 B12 Injection Consultation Your GLP-1-B12 journey begins with a consultation